ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $925,000 | -9.1% | 74,396 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,018,000 | +85.1% | 74,396 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $550,000 | +15.8% | 74,396 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $475,000 | +2.2% | 74,396 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $465,000 | +7.1% | 74,396 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $434,000 | -40.0% | 74,396 | -14.9% | 0.00% | -50.0% |
| Q2 2015 | $723,000 | -3.5% | 87,429 | -3.8% | 0.00% | 0.0% |
| Q1 2015 | $749,000 | +20.0% | 90,880 | 0.0% | 0.00% | +100.0% |
| Q4 2014 | $624,000 | +27.1% | 90,880 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $491,000 | -15.2% | 90,880 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $579,000 | -25.5% | 90,880 | -5.7% | 0.00% | -50.0% |
| Q1 2014 | $777,000 | +17.4% | 96,403 | -0.6% | 0.00% | 0.0% |
| Q4 2013 | $662,000 | -62.9% | 97,030 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $1,785,000 | +4.9% | 97,030 | -0.2% | 0.00% | -20.0% |
| Q2 2013 | $1,701,000 | – | 97,242 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
| Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
| Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
| Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
| Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
| Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
| Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
| 1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
| HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |